Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.

Kundel A, Thompson GB, Richards ML, Qiu LX, Cai Y, Schwenk FW, Lteif AN, Pittock ST, Kumar S, Tebben PJ, Hay ID, Grant CS.

J Clin Endocrinol Metab. 2014 Feb;99(2):399-406. doi: 10.1210/jc.2013-2617. Epub 2013 Dec 11.

PMID:
24423286
2.

Transgenic RNAi applications in the mouse.

Seibler J, Schwenk F.

Methods Enzymol. 2010;477:367-86. doi: 10.1016/S0076-6879(10)77019-1.

PMID:
20699151
3.

The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis.

Glaser S, Lubitz S, Loveland KL, Ohbo K, Robb L, Schwenk F, Seibler J, Roellig D, Kranz A, Anastassiadis K, Stewart AF.

Epigenetics Chromatin. 2009 Apr 6;2(1):5. doi: 10.1186/1756-8935-2-5.

4.

Central insulin action regulates peripheral glucose and fat metabolism in mice.

Koch L, Wunderlich FT, Seibler J, Könner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Brüning JC.

J Clin Invest. 2008 Jun;118(6):2132-47. doi: 10.1172/JCI31073.

5.

Reversible gene knockdown in mice using a tight, inducible shRNA expression system.

Seibler J, Kleinridders A, Küter-Luks B, Niehaves S, Brüning JC, Schwenk F.

Nucleic Acids Res. 2007;35(7):e54. Epub 2007 Mar 21.

6.

Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity.

Plum L, Ma X, Hampel B, Balthasar N, Coppari R, Münzberg H, Shanabrough M, Burdakov D, Rother E, Janoschek R, Alber J, Belgardt BF, Koch L, Seibler J, Schwenk F, Fekete C, Suzuki A, Mak TW, Krone W, Horvath TL, Ashcroft FM, Brüning JC.

J Clin Invest. 2006 Jul;116(7):1886-901. Epub 2006 Jun 22.

7.

Single copy shRNA configuration for ubiquitous gene knockdown in mice.

Seibler J, Küter-Luks B, Kern H, Streu S, Plum L, Mauer J, Kühn R, Brüning JC, Schwenk F.

Nucleic Acids Res. 2005 Apr 14;33(7):e67.

8.

A genetic switch for epilepsy in adult mice.

Krestel HE, Shimshek DR, Jensen V, Nevian T, Kim J, Geng Y, Bast T, Depaulis A, Schonig K, Schwenk F, Bujard H, Hvalby Ø, Sprengel R, Seeburg PH.

J Neurosci. 2004 Nov 17;24(46):10568-78.

9.

Hybrid embryonic stem cell-derived tetraploid mice show apparently normal morphological, physiological, and neurological characteristics.

Schwenk F, Zevnik B, Brüning J, Röhl M, Willuweit A, Rode A, Hennek T, Kauselmann G, Jaenisch R, Kühn R.

Mol Cell Biol. 2003 Jun;23(11):3982-9.

10.

Rapid generation of inducible mouse mutants.

Seibler J, Zevnik B, Küter-Luks B, Andreas S, Kern H, Hennek T, Rode A, Heimann C, Faust N, Kauselmann G, Schoor M, Jaenisch R, Rajewsky K, Kühn R, Schwenk F.

Nucleic Acids Res. 2003 Feb 15;31(4):e12.

11.

Stringent doxycycline dependent control of CRE recombinase in vivo.

Schönig K, Schwenk F, Rajewsky K, Bujard H.

Nucleic Acids Res. 2002 Dec 1;30(23):e134.

12.

Conditional knockout mice.

Kühn R, Schwenk F.

Methods Mol Biol. 2003;209:159-85. No abstract available.

PMID:
12357951
13.
14.

Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA.

Diabetes. 2001 Mar;50(3):565-72.

15.
16.

Temporally and spatially regulated somatic mutagenesis in mice.

Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF.

Nucleic Acids Res. 1998 Mar 15;26(6):1427-32.

17.

Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.

Clausen BE, Waldburger JM, Schwenk F, Barras E, Mach B, Rajewsky K, Förster I, Reith W.

Immunity. 1998 Feb;8(2):143-55.

18.

Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains.

Schwenk F, Sauer B, Kukoc N, Hoess R, Müller W, Kocks C, Kühn R, Rajewsky K.

J Immunol Methods. 1997 Sep 24;207(2):203-12.

PMID:
9368647
19.

The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.

Kaisho T, Schwenk F, Rajewsky K.

Science. 1997 Apr 18;276(5311):412-5.

20.

Advances in gene targeting methods.

Kühn R, Schwenk F.

Curr Opin Immunol. 1997 Apr;9(2):183-8. Review.

PMID:
9099792
21.

Conditional gene targeting.

Rajewsky K, Gu H, Kühn R, Betz UA, Müller W, Roes J, Schwenk F.

J Clin Invest. 1996 Aug 1;98(3):600-3. Review. No abstract available.

22.

A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Schwenk F, Baron U, Rajewsky K.

Nucleic Acids Res. 1995 Dec 25;23(24):5080-1. No abstract available.

23.

Inducible gene targeting in mice.

Kühn R, Schwenk F, Aguet M, Rajewsky K.

Science. 1995 Sep 8;269(5229):1427-9.

PMID:
7660125
26.

Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.

Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Arcangeli M, Aoki T, Sorensen J, Berger M, et al.

J Clin Invest. 1988 May;81(5):1563-71.

27.

Supplemental Content

Loading ...
Support Center